Strategic Wealth Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.45K Sell
40
-256
-86% -$21.3K ﹤0.01% 903
2026
Q2
$19.9K Hold
296
– – ﹤0.01% 749
2026
Q1
$18.6K Hold
296
– – ﹤0.01% 726
2025
Q4
$19.6K Sell
296
-1,663
-85% -$108K ﹤0.01% 703
2025
Q3
$132K Buy
1,959
+1,919
+4,798% +$152K 0.01% 396
2025
Q2
$3.49K Buy
+40
New +$3.14K ﹤0.01% 946

Other funds holding DXCM

Strategic Wealth Partners's DXCM Position: Q3 2026 in Review

Strategic Wealth Partners reduced its DexCom (DXCM) stake by 86% in Q3 2026, selling an estimated $21.3K and leaving 40 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Strategic Wealth Partners first reported a position in DXCM in Q2 2025 and has held it in 6 quarters since. The position peaked at $132K in Q3 2025. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Strategic Wealth Partners held 40 shares of DexCom worth $3.45K as of Q3 2026.
  • Strategic Wealth Partners sold 256 DexCom shares in Q3 2026, an estimated $21.3K.
  • DexCom made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q3 2026, its #903 holding.
  • Strategic Wealth Partners first reported a position in DexCom in Q2 2025 and has held it in 6 quarters since.
  • Strategic Wealth Partners's DexCom position peaked at $132K in Q3 2025.
  • 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Strategic Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.